Hypertrophic Cardiomyopathy Pilot Study

Completed

Conditions studied: Hypertrophic Cardiomyopathy, Coronary Artery Disease

In brief

This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate

Key facts

Study ID

NCT02806479

Run by

Oregon Health and Science University

People needed

40

Starts

2016-09-01

Expected to finish

2020-09-01

Last updated by the study team

2020-09-16

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed HCM
• Documented history of sustained ventricular tachyarrhythmia or resuscitated sudden cardiac arrest
• Maximal left ventricular wall thickness of > 30mm
• Extensive fibrosis on cardiac MRI (>15% of total myocardial volume)
• >7.5%/5-year risk of sudden cardiac death as determined by HCM risk-SCD

You may not qualify if…

• age < 18 years
• Pregnancy
• Atrial Fibrillation

Where it is running

• Oregon Health and Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.